Related Experiment Video
Updated: May 21, 2026

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
Published on: May 30, 2019
ASSESSMENT OF NON-ENDOCRINOLOGIST PHYSICIANS' AWARENESS OF DIABETES TECHNOLOGIES: A NATIONWIDE SURVEY IN TURKEY
E Barsal Çetiner1, Z Donbaloğlu1
1Antalya City Hospital, Department of Pediatric Endocrinology, Antalya, Turkey.
Context:
Continuous glucose monitoring (CGM) and insulin pump technologies have improved the management of type 1 diabetes mellitus, particularly in childhood. Physicians' knowledge and awareness of these devices are essential for their effective use.
Objective:
To assess physicians' knowledge and awareness regarding CGM and insulin pump systems.
Design:
This study was designed as a descriptive cross-sectional study.
Subjects And Methods:
A total of 203 non-endocrinologist physicians from different regions and healthcare levels in Turkey participated. A 33-item questionnaire based on the ISPAD guidelines was used to evaluate knowledge.
Results:
Although 95.6% of participants had heard of CGM devices, only 14.8% correctly identified interstitial fluid as the medium of glucose measurement. While 34.5% knew that 6-10 daily fingerstick measurements are recommended, only half were aware that CGMs record 288 readings per day. Some mistakenly believed CGMs deliver insulin or require insertion in an operating room. Knowledge regarding insulin pump indications and age suitability was also insufficient. Knowledge levels did not significantly differ by specialty, academic title, or institution type.
Conclusions:
Non-endocrinologist physicians show limited knowledge of diabetes technologies, which may hinder patient education and management. Structured continuing medical education programs are needed to strengthen physicians' competencies in this rapidly advancing field.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Hyperglycemia